1. Besbes S, Mirshahi M, Pocard M, et al. New dimension in therapeutic targeting of BCL-2 family proteins. Oncotarget. 2015;6(15):12862–71.
2. Seymour J. ABT-199 for chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2014;12(10):698–700.
3. Su J, Zhou L, Xia MH, et al. Bcl-2 family proteins are involved in the signal crosstalk between endoplasmic reticulum stress and mitochondrial dysfunction in tumor chemotherapy resistance. Biomed Res Int. 2014;2014:234370.
4. AbbVie Inc., Genentech Inc. Venclexta™ (venetoclax): US prescribing information. 2016. http://www.fda.gov . Accessed 21 Apr 2016.
5. US Food and Drug Administration. Venetoclax (Venclexta) tablets. 2016. http://www.fda.gov . Accessed 2 May 2016.